Pritam Sadhukhan

Dr. Pritam Sadhukhan

National Institutes of Health, Bethesda, Maryland, USA
+1
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
PSPritam Sadhukhan
Pritam Sadhukhan
MKMousumi Kundu
Mousumi Kundu
SCSharmistha Chatterjee
Sharmistha Chatterjee
NGNoyel Ghosh
Noyel Ghosh
PMPrasenjit Manna
Prasenjit Manna
PSParames Sil
Parames Sil

1 July 2019 in Journal of Advanced Research
Verified
Journal Article
Open access
MKMousumi Kundu
Mousumi Kundu
PSPritam Sadhukhan
Pritam Sadhukhan
NGNoyel Ghosh
Noyel Ghosh
SCSharmistha Chatterjee
Sharmistha Chatterjee
PMPrasenjit Manna
Prasenjit Manna
PSParames Sil
Parames Sil
Nanoparticle-mediated targeted delivery of bioactive natural compounds has recently been gaining much interest for breast cancer therapy. Herein, phenyl boronic acid (PBA)-conjugated and pH-responsive ZnO nanoparticles (diameter ∼40 nm) were synthesized for the tumor tissue-specific delivery of curcumin. PBA conjugation facilitates the targeted delivery of curcumin to the sialic acid overexpressed in breast cancer cell membranes. Curcumin-loaded ZnO nanoparticles (ZnO-PBA-Curcumin) caused apoptotic cell death in MCF-7 human breast cancer cells by inducing oxidative stress and mitochondrial damage. Further, in vivo intravenous (i.v.) administration of ZnO-PBA-Curcumin was found to effectively decrease tumor growth in Ehrlich ascites carcinoma (EAC) tumor-bearing mice via the enhanced accumulation of curcumin. Interestingly, ZnO-PBA-Curcumin did not show any signs of systemic toxicity. The cytotoxic potential of the nanohybrid ZnO-PBA-Curcumin is attributed to the combinatorial cytotoxic effects of curcumin and ZnO in cancer cells. Collectively, ZnO-PBA-Curcumin may represent a potential treatment modality for breast cancer therapy. This study provides insight into the tumor cell targeting mechanism using PBA functionalization, and the anticancer efficacy of curcumin-loaded pH-sensitive nanohybrids can be attributed to the differential oxidative stress-inducing properties of curcumin and Zn+2 ions.

24 May 2016 in BioFactors
Verified
Journal Article
Closed access
PDF file
SSSukanya Saha
Sukanya Saha
PSPritam Sadhukhan
Pritam Sadhukhan
PSParames Sil
Parames Sil

1 January 2017 in Toxicology Reports
Verified
Journal Article
Open access
PBPriyanka Basak
Priyanka Basak
PSPritam Sadhukhan
Pritam Sadhukhan
PSPoulami Sarkar
Poulami Sarkar
PSParames Sil
Parames Sil
The Nuclear factor erythroid2-related factor2 (Nrf2), a master regulator of redox homoeostasis, is a key transcription factor regulating a wide array of genes for antioxidant and detoxification enzymes. It protects organs from various kinds of toxic insults. On the other hand, activation of Nrf2 is also correlated with cancer progression and chemoresistance. Downregulation of Nrf2 activity has attracted an increasing amount of attention as it may provide an alternative cancer therapy. In this review, we examine recent studies on roles of Nrf2 in several pathophysiological conditions emphasising cancer. We discuss elaborately the current knowledge on Nrf2 regulation including KEAP1-dependent and KEAP1-independent cascades. KEAP1/Nrf2 system is a master regulator of cellular response against a variety of environmental stresses. We also highlight several tightly controlled regulations of Nrf2 by numerous proteins, small molecules, toxic metals, etc. In addition, we evaluate the possible therapeutic approaches of increasing chemosensitivity via modulating Nrf2 signaling.

1 April 2015 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
KSKrishnendu Sinha
Krishnendu Sinha
PSPritam Sadhukhan
Pritam Sadhukhan
SSSukanya Saha
Sukanya Saha
PPPabitra Bikash Pal
Pabitra Bikash Pal
PSParames Sil
Parames Sil

1 January 2019 in Toxicology Reports
Verified
Journal Article
Open access
PSPritam Sadhukhan
Pritam Sadhukhan
MKMousumi Kundu
Mousumi Kundu
SRShallu Rana
Shallu Rana
RKRajesh Kumar
Rajesh Kumar
JDJoydeep Das
Joydeep Das
PSParames Sil
Parames Sil
In the present study, we report the microwave-induced synthesis of fluorescent zinc oxide nanorods (ZnO) and their usage as a cargo material to carry hydrophobic drug, quercetin. TEM and SEM showed the rod-shape morphology of our synthesized ZnO. XRD showed several diffraction peaks correspond to a hexagonal wurtzite structure. The optical and chemical natures of these nanorods were also confirmed from the UV-vis (showed a distinct absorption bands from 361 to 395 nm) and FTIR spectrum (showed absorption band specific to Zn-O stretching). The synthesized ZnO also showed fluorescence emission at around 550 nm when excited under UV irradiation. Quercetin was loaded onto ZnO surface via employing a metal ion-ligand coordination bond, (ZnO/QR), which exhibit pH-sensitive release behavior. ZnO/QR displayed superior drug loading content (42%) and loading efficiency (72.4%). in vitro assays showed that ZnO/QR exhibited higher anticancer, as well as antibacterial activities compared with free quercetin and ZnO. All these results highlight the synthesis of ZnO nanorods under microwave irradiation, which can be used as a plausible therapeutic option for bioimaging and drug delivery purpose.